Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Daniel Clair Added: 8 months ago
ISET 2025 - Safety and efficacy outcomes of an intravascular lithotripsy (IVL) catheter used for the treatment of moderate to severely calcified lesions show a high ability to deliver the catheter with access to the lesion and very low rates of myocardial infarction and distal embolisation.Dr Daniel Clair (Vanderbilt University Medical Center, TN, US) joins us to discuss the key findings from the… View more
Added: 4 months ago
Interventional Cardiology 2025;20:e22 View more
Author(s): Oliver Schlager Added: 2 months ago
ESC Congress 2025 - New guidelines for catheter-based VTE therapy emphasise the importance of involving vascular experts, and performing procedures in experienced centers.Dr Oliver Schlager (Medical University of Vienna, AT) joins us to discuss the newly released 2025 ESVM Guidelines on Interventional Treatment of Venous Thromboembolism, endorsed by European national societies of Vascular… View more
Author(s): Andrew Holden Added: 6 months ago
What are the unique features of the new intravascular lithotripsy (IVL) devices addressing calcified tibial disease?Prof Andrew Holden (Auckland City Hospital, Auckland, NZ) joins us to discuss two new devices addressing calcified tibial disease, the Shockwave E8 catheter and the Shockwave Javelin catheter. Prof Holden then evaluates the safety and efficacy findings from the Disrupt PAD BTK II… View more
Job title: Cardiologist
Dr Tetsuma Kawaji is a Cardiologist at Mitsubishi Kyoto Hospital, Kyoto, JP.Dr Kawaji's research primarily focuses on arrhythmias, electrophysiology and the optimisation of catheter ablation techniques. View more
Author(s): Oussama M Wazni Added: 11 months ago
AHA Conference 2024 - Safety and efficacy outcomes comparing left atrial appendage (LAA) closure with the WATCHMAN FLX device to oral anticoagulation (OAC) following atrial fibrillation (AF) catheter ablation.Dr Oussama Wazni (The Cleveland Clinic Foundation, Ohio, US) joins us onsite at AHA Conference to discuss the findings from OPTION (NCT03795298).OPTION is a prospective, multi-center, multi… View more
Research Area(s) / Expertise:
Prof. Ken Okumura served as a Professor of Medicine at Hirosaki University School of Medicine from 1996 to 2016. He also served as a President of the Japanese Heart Rhythm Society (JHRS) from 2012 to 2016. He is now working at Saiseikai Kumamoto Hospital Cardiovascular Center, Japan, while providing the latest interventional treatments for cardiac arrhythmias especially catheter ablation of AF… View more
Job title: MD
Elad Anter, is an Endowed Professor of Medicine, Associate Section Head of Cardiac Electrophysiology, and Director of the Josephson-Wit Research Laboratory in the Electrophysiology Section of the Department of Cardiovascular Medicine of the Cleveland Clinic. Dr. Anter is an electrophysiologist, scientist, and innovator in the field of catheter ablation, specializing in catheter ablation of atrial… View more